Key facts
- Notable investors include iAccel (Seongnam-si).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for JH Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for JH Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About JH Biotechnology
Developer of human-centered biotechnology and health technologies designed to contribute to human health and well-being. The company develops biotechnology and related health technologies, enabling applications in life sciences, though specific product and service details are not publicly disclosed.
- Sector
- Healthcare
- HQ
- Gimhae, South Korea
- Founded
- 2023
- Website
- jhbiotech.net/
- Ownership
- Privately Held (backing)
JH Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in JH Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on JH Biotechnology in its N-PORT filings yet. We sweep new filings monthly.